Article ; Online: Eosinophilic colitis: epidemiology, clinical features, and current management.
Therapeutic advances in gastroenterology
2011 Volume 4, Issue 5, Page(s) 301–309
Abstract: ... of EC, its epidemiology, clinical manifestations, diagnosis, and treatment. ... biologics that target interleukin-5 (IL-5) and IgE. This review article summarizes the current knowledge ... weight loss. Endoscopic changes are generally modest, featuring edema and patchy granularity ...
| Abstract | Primary eosinophilic gastrointestinal disorders (EGIDs) represent a spectrum of inflammatory gastrointestinal disorders in which eosinophils infiltrate the gut in the absence of known causes for such tissue eosinophilia. EGIDs can be subgrouped as eosinophilic esophagitis (EE), eosinophilic gastroenteritis (EG), and eosinophilic colitis (EC). The least frequent manifestation of EGIDs is EC. EC is a heterogeneous entity with a bimodal age distribution, presenting with either an acute self-limited bloody diarrhea in otherwise healthy infants or as a more chronic relapsing colitis in young adults. The pathophysiology of primary EC appears related to altered hypersensitivity, principally as a food allergy in infants and T lymphocyte-mediated (i.e. non-IgE associated) in young adults. In adults, symptoms include diarrhea, abdominal pain, and weight loss. Endoscopic changes are generally modest, featuring edema and patchy granularity. Although standardized criteria are not yet established, the diagnosis of EC depends on histopathology that identifies an excess of eosinophils. Therapeutic approaches are based on case reports and small case series, as prospective randomized controlled trials are lacking. Eosinophilic colitis in infants is a rather benign, frequently food-related entity and dietary elimination of the aggressor often resolves the disorder within days. Adolescent or older patients require more aggressive medical management including: glucocorticoids, anti-histamines, leukotriene receptors antagonists as well as novel approaches employing biologics that target interleukin-5 (IL-5) and IgE. This review article summarizes the current knowledge of EC, its epidemiology, clinical manifestations, diagnosis, and treatment. |
|---|---|
| Language | English |
| Publishing date | 2011-09-13 |
| Publishing country | England |
| Document type | Journal Article |
| ZDB-ID | 2440710-0 |
| ISSN | 1756-2848 ; 1756-283X |
| ISSN (online) | 1756-2848 |
| ISSN | 1756-283X |
| DOI | 10.1177/1756283X10392443 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.